EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • August 2nd, 2022 • Axim Biotechnologies, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 2nd, 2022 Company Industry JurisdictionThis equity purchase agreement is entered into as of July 14, 2022 (this “Agreement”), by and between AXIM Biotechnologies, Inc., a Nevada corporation (the “Company”), and Cross & Company, a Nevada corporation (the “Investor”).